Eris Lifesciences Limited
ERIS · NSE · ₹1,189 a share (close of 05 Oct 2026)
Available company data, source links and archived checks for Eris Lifesciences Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Revenue rose 13.0%; Net profit was ₹143.32 crore.
Quarter ended 2026-06-30 · consolidated · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Jun 2026 | Revenue: ₹873 cr | +13.0% | Net profit: ₹143 cr | +14.6% | 16.4% | Company filing source |
| Mar 2026 | Revenue: ₹757 cr | +7.3% | Net profit: ₹279 cr | +172.7% | 36.9% | Company filing source |
| Dec 2025 | Revenue: ₹807 cr | — | Net profit: ₹109 cr | — | 13.5% | Company filing source |
| Sep 2025 | Revenue: ₹792 cr | — | Net profit: ₹134 cr | — | 17.0% | Company filing source |
| Jun 2025 | Revenue: ₹773 cr | +7.4% | Net profit: ₹125 cr | +39.9% | 16.2% | Company filing source |
| Mar 2025 | Revenue: ₹705 cr | — | Net profit: ₹102 cr | — | 14.5% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
Amit Indubhusan Bakshi 42.3%Lilac Investments Limited 8.6%Hdfc Small Cap Fund 8.3%Franklin India Small Cap Fund 4.3%Inderjeet Singh Negi 4.3%register as filed
2026-06-30
Filing timeline — what the company told the exchange
- Eris Lifesciences Limited has informed the Exchange regarding Resignation of Mr Krishnakumar vaidyanathan as Executive Director of the company w.e.f. close of S…
05 Oct 2026 · document
- Eris Lifesciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015…
28 Sep 2026 · document
- Shareholders meeting. Eris Lifesciences Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 25, 2026. Furth…
25 Sep 2026 · document
- Shareholders meeting. Eris Lifesciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 25, 2026…
25 Sep 2026 · document
- Allotment of Securities. Eris Lifesciences Limited has informed the Exchange regarding allotment of 155264 securities pursuant to ESOP/ESPS at its meeting held …
22 Sep 2026 · document
- Eris Lifesciences Limited has informed the Exchange regarding Appointment of Mr as Non- Executive Independent Director of the company w.e.f. September 26, 2026.…
21 Sep 2026 · document
- Eris Lifesciences Limited has informed the Exchange regarding Resignation of Mr Krishnakumar Vaidyanathan as Executive Director of the company w.e.f. September …
11 Sep 2026 · document
- Eris Lifesciences Limited has informed the Exchange about Rumour Verification - Regulation 30(11)…
10 Sep 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time